tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
PHAT
Phathom Pharmaceuticals
RESEARCH TOOLSreports
Want to see PHAT full AI Analyst Report?

Phathom Pharmaceuticals (PHAT) Stock News & Sentiment

587 Followers
Phathom Pharmaceuticals Signals Strong Growth on Earnings Call
Premium
Company Announcements
Phathom Pharmaceuticals Signals Strong Growth on Earnings Call
9d ago
PHAT
Phathom Pharmaceuticals Charts Profitable Path After Ramp-Up
Premium
Company Announcements
Phathom Pharmaceuticals Charts Profitable Path After Ramp-Up
2M ago
PHAT
Phathom Pharmaceuticals: Early VOQUEZNA Traction, Strengthened Balance Sheet, and Clear Path to Profitability Support Buy Rating
Premium
Ratings
Phathom Pharmaceuticals: Early VOQUEZNA Traction, Strengthened Balance Sheet, and Clear Path to Profitability Support Buy Rating
2M ago
PHAT
Phathom Pharmaceuticals Announces $130 Million Public Offering
Premium
Company Announcements
Phathom Pharmaceuticals Announces $130 Million Public Offering
4M ago
8K
PHAT
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
5M ago
LXEO
PHAT
Phathom Pharmaceuticals Begins Phase 2 EoE Trial
Premium
Company Announcements
Phathom Pharmaceuticals Begins Phase 2 EoE Trial
6M ago
8K
PHAT
Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges
Premium
Company Announcements
Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges
6M ago
PHAT
More PHAT News >

PHAT News on the Web

Analysts Have Conflicting Sentiments on These Healthcare Companies: Allogene Therapeutics (ALLO), Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)
TipRanks News
Neutral
Phathom Pharmaceuticals (PHAT) was upgraded to a Buy Rating at Barclays
TipRanks News
Bullish
Phathom Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays
TipRanks News
Neutral
Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study
Zacks
Neutral
ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy
Zacks
Bearish
Phathom Pharmaceuticals management to meet with Cantor
TipRanks News
Bullish
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
Zacks
Bullish
Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli
Zacks
Bearish

News Score - Last 7 Days

Neutral
PHAT
Sector Average
Media Buzz
Currently, no data available
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PHAT’s Media Buzz Sentiment?
Currently, no data Available
What is PHAT’s weekly average amount of articles?
Currently, no data Available
What is PHAT’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TVTXTravere Therapeutics
HVOOpen Orphan Plc
PBMPsyence Biomedical
QDELQuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week